We are live on ! Find out more
ZYME icon

Zymeworks

120 hedge funds and large institutions have $327M invested in Zymeworks in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 19 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 19

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

5% more funds holding

Funds holding: 114120 (+6)

4% more call options, than puts

Call options by funds: $846K | Put options by funds: $816K

4.41% less ownership

Funds ownership: 90.95%86.54% (-4.4%)

53% less capital invested

Capital invested by funds: $694M → $327M (-$367M)

Holders
120
Holders Change
+6
Holders Change %
+5.26%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
52
Reduced
19
Closed
23
Calls
$846K
Puts
$816K
Net Calls
+$30K
Net Calls Change
-$48K

ZYME Hedge Fund Activity: Q1 2022 in Review

120 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2022, worth a combined $327M — down 53% from $694M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ZYME positions and 23 closed out — a net gain of 6 holders — while 52 added to existing stakes and 19 trimmed.

The largest buyer was Armistice Capital, adding an estimated $40.2M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $28.1M sold.

  • 120 institutional investors held Zymeworks (ZYME) as of Q1 2022, up from 114 in Q4 2021.
  • Funds reported $327M of Zymeworks stock for Q1 2022, down 53% quarter-over-quarter.
  • 29 funds opened new Zymeworks positions in Q1 2022 and 23 closed out, a net change of +6 holders.
  • The largest Zymeworks buyer in Q1 2022 was Armistice Capital, an estimated $40.2M added.
  • The largest Zymeworks seller in Q1 2022 was T. Rowe Price Associates, an estimated $28.1M sold.

Based on aggregated 13F filings for Q1 2022.